| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.01 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.01 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.01 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.02 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |